Microbot Medical Inc (MBOT) Stock Price, Quote & News

Company Profile

Microbot Medical Inc. is a medical device company that focuses on transforming endovascular procedures through advanced robotic technology. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, endovascular, and neurovascular operations. It also provides No...

Industry: Medical Instruments & Supplies

Sector: Healthcare

Phone: 781 875 3605

Website: microbotmedical.com

Address:

175 Derby Street, Bld. 27, Hingham, United States

ImCrazy Apr. 8 at 1:51 AM

$MBOT

0 · Reply

trigger_finger Apr. 7 at 11:35 PM

$MBOT

3 · Reply

trigger_finger Apr. 7 at 4:32 PM

$MBOT Yikes, this company doesn't do earnings calls? Its one of those "go read the 10qs". Not even a letter to shareholders. No me gusta Señors and Señoritas. And zero planned haptic control on this thing, something Nintendo did back in the 90's...........wth??

1 · Reply

DragonAlgo Apr. 7 at 1:17 PM

🐉 $MBOT PUT — DragonAlgo® Signal Contract: MBOT PUT Expiry: 2026-04-17 | Strike: $2.50 | Type: PUT Option Plan (premium): Entry: $0.25 Stop: $0.18 TP1: $0.33 TP2: $0.42 TP3: $0.60 🔗 https://dragonalgo.com

0 · Reply

Vladdavceo Apr. 7 at 1:15 AM

$BIOLLM.X $MBOT

0 · Reply

MakeM0ney_444 Apr. 6 at 6:57 PM

$MBOT amazing, but why didn’t this move the sp much today? Do we see a big jump next week?

2 · Reply

trigger_finger Apr. 6 at 6:04 PM

$MBOT If support breaks, this is what I would be looking at.

3 · Reply

Eddypgil Apr. 6 at 4:05 PM

$MBOT building in hingham looks pretty sleepy. Maybe the engineer at Microbot can try and get liberty to work with Synchrony

1 · Reply

ImCrazy Apr. 6 at 3:54 PM

$MBOT https://www.sirweb.org/education/events/sir-2026-annual-scientific-meeting/

0 · Reply

ImCrazy Apr. 6 at 3:53 PM

$MBOT Get Ready!!!! HINGHAM, Mass., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY® Endovascular Robotic System, announced that its LIBERTY® System, the first FDA cleared single-use, remotely operated robotic system for peripheral endovascular procedures, is now commercially available in the U.S. The Limited Market Release (LMR) will introduce LIBERTY® to selected high procedure volume regions where the Company already experienced preliminary demand for LIBERTY®. The LMR will focus on collecting real-world insights from potential high-volume users to guide responsible growth and ensure consistent quality and performance, leading to the expected Full Market Release (FMR) during the Society of Interventional Radiology (SIR), the largest U.S. medical conference for Interventional Radiology, in April 2026. https://ir.microbotmedical.com/news-releases/news-release-details/microbot-medicalr-commences-limited-market-release-its-libertyr

0 · Reply

Emory Healthcare Successfully Completes Robotic Peripheral Endovascular Procedures using Microbot Medical®'s LIBERTY® Endovascular Robotic System

Mar 24, 2026, 8:30 AM EDT - 14 days ago

Microbot Medical® Strengthens LIBERTY® Endovascular Robotic System Position with Publication of its ACCESS PVI Pivotal Study in Leading Peer-Reviewed Medical Journal

Mar 17, 2026, 8:40 AM EDT - 21 days ago

Microbot Medical® to Participate at the 38th Annual Roth Conference

Mar 10, 2026, 8:30 AM EDT - 4 weeks ago

Microbot Medical® to Participate at the Oppenheimer 36th Annual Healthcare MedTech & Services Conference for The First Time

Mar 4, 2026, 8:30 AM EST - 4 weeks ago

Microbot Medical® Aligns with Recently Adopted Policy of the Largest U.S.-Based Medical Association to Expand Protection for Healthcare Professionals from Ionizing Radiation

Mar 3, 2026, 9:00 AM EST - 5 weeks ago

Microbot Medical® Confirms Continued Operational and Commercial Stability Amid Current Geopolitical Event

Feb 24, 2026, 1:48 PM EST - 6 weeks ago

Tampa General Hospital Adopts Small-Cap Microbot Medical's Robotic System

Feb 24, 2026, 8:30 AM EST - 6 weeks ago

Tampa General Hospital is the First Health System in Florida to Adopt the LIBERTY® Endovascular Robotic System

Feb 19, 2026, 8:30 AM EST - 6 weeks ago

Microbot Medical®'s LIBERTY® Endovascular Robotic System Continues to Expand Market Visibility; Being Featured at an Industry Leading Innovation Conference

Feb 12, 2026, 8:30 AM EST - 7 weeks ago

Microbot Medical®'s LIBERTY® Endovascular Robotic System Highlighted at a Leading Vascular Disease Management Conference

Feb 5, 2026, 8:30 AM EST - 2 months ago

Microbot Medical® to Leverage Current Users Experience of the LIBERTY® Endovascular Robotic System at Key Oncology Conference to Support Commercial Adoption

Jan 12, 2026, 8:30 AM EST - 3 months ago

Microbot Medical Continues its 2025 Momentum; Announces Key 2026 Milestones

Nov 26, 2025, 8:30 AM EST - 4 months ago

Microbot Medical® Announces Emory University Hospital as the First Hospital in the World to Adopt the New LIBERTY® Endovascular Robotic System

Nov 5, 2025, 8:30 AM EST - 5 months ago

Microbot Medical® Commences the Limited Market Release of its LIBERTY® Endovascular Robotic System in the U.S.

Oct 16, 2025, 8:30 AM EDT - 6 months ago

Microbot Medical® to Commercially Debut the LIBERTY® System at The Symposium on Clinical Interventional Oncology Annual Meeting

Oct 14, 2025, 8:30 AM EDT - 6 months ago

Microbot Medical® Secures U.S. Based Logistics Partner to Support the Commercialization of Its LIBERTY® Endovascular Robotic System

Oct 7, 2025, 8:00 AM EDT - 6 months ago

Microbot Medical Announces Final Closing of Exercise of Outstanding Preferred Investment Options of Up to $92.2 Million in Gross Proceeds

Oct 1, 2025, 9:00 AM EDT - 6 months ago

Microbot Medical® Receives First Patent in Japan as it Continues to Broaden its Global Intellectual Property Portfolio

Sep 23, 2025, 8:30 AM EDT - 7 months ago

Miocrbot Medical® CEO to Discuss Recent FDA Clearance of the LIBERTY® Endovascular Robotic System

Sep 16, 2025, 3:37 PM EDT - 7 months ago

Microbot Medical Announces First Closing of Exercise of Outstanding Preferred Investment Options of Up to $92.2 Million in Gross Proceeds

Sep 15, 2025, 8:00 AM EDT - 7 months ago

Microbot Medical Announces Exercise of Outstanding Preferred Investment Options for Up to $92.2 Million in Gross Proceeds

Sep 9, 2025, 8:28 AM EDT - 7 months ago

REMINDER: Microbot Medical to Highlight FDA 510(k) Clearance of the LIBERTY Endovascular Robotic System at the H.C. Wainwright Annual Investor Conference

Sep 8, 2025, 8:28 AM EDT - 7 months ago

Microbot Medical® Receives FDA 510(k) Clearance for Its LIBERTY® Endovascular Robotic System

Aug 20, 2025, 8:30 AM EDT - 8 months ago

Microbot Medical® Granted U.S. Patent that Significantly Expands Potential Market Applications

Aug 5, 2025, 8:30 AM EDT - 8 months ago

Microbot Medical® Receives Non-Dilutive Grant to Enhance Operational Capabilities

Jul 22, 2025, 8:30 AM EDT - 9 months ago

Microbot Medical® Expands Commercial Leadership with Appointment of Christina Bailey as VP of Sales

Jul 8, 2025, 8:30 AM EDT - 9 months ago

Microbot Medical® to Open Inaugural Endovascular Robotics Session at the Society of Robotic Surgery Annual Meeting

Jun 30, 2025, 8:30 AM EDT - 10 months ago

Microbot Medical® Added to the Russell Microcap® Index

Jun 17, 2025, 8:30 AM EDT - 10 months ago

Microbot Medical Strengthens Global IP Portfolio with Newly Granted Patent in China

Jun 9, 2025, 8:30 AM EDT - 10 months ago

Microbot Medical Continues to Strengthen Commercial Capabilities in Preparation for the anticipated Q3 2025 Launch of its LIBERTY® Endovascular Robotic System

Jun 5, 2025, 8:30 AM EDT - 10 months ago

Microbot Medical Selected for Preliminary Inclusion to Russell Microcap® Index

Apr 23, 2025, 8:30 AM EDT - 1 year ago

Microbot Medical® Bolsters Commercial Leadership Team with the Addition of Experienced Healthcare Officers

Apr 9, 2025, 8:30 AM EDT - 1 year ago

Microbot Medical® Shares Results from Its Pivotal Clinical Trial, Achieving 100% Robotic Navigation Success for the LIBERTY® Endovascular Robotic System

Apr 1, 2025, 8:30 AM EDT - 1 year ago

REMINDER: Microbot Medical Announces Data from the Company's ACCESS-PVI trial will be Presented via Podium Presentation at Society of Interventional Radiology Annual Meeting

Mar 4, 2025, 8:30 AM EST - 1 year ago

Microbot Medical Appoints Seasoned Endovascular Sales Executive to Lead its U.S. Sales Activities for LIBERTY® Endovascular Robotic System

Feb 25, 2025, 8:30 AM EST - 1 year ago

Robotic Telesurgery Data from Collaboration with Corewell Health™ Accepted for Presentation at the Cardiovascular Research Technologies Annual Meeting

Feb 11, 2025, 6:15 PM EST - 1 year ago

Microbot Medical Closes $13 Million Registered Direct Offering

Feb 10, 2025, 8:00 AM EST - 1 year ago

Microbot Medical Announces $13 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

Jan 10, 2025, 10:25 AM EST - 1 year ago

Microbot Medical Closes $8.6 Million Registered Direct Offering

Jan 7, 2025, 4:15 PM EST - 1 year ago

Microbot Medical Raises a Total of Approximately $11.8 Million in Gross Proceeds from Registered Direct Offering and Previously Announced ATM Facility

Dec 30, 2024, 8:30 AM EST - 1 year ago

Microbot Medical® Concludes 2024 by Achieving Key Milestones Culminating in FDA Submission for the Commercialization of LIBERTY®

Dec 10, 2024, 10:18 AM EST - 1 year ago

Microbot Medical® CEO Harel Gadot to Discuss Endovascular Robotics on Benzinga All Access

Oct 15, 2024, 8:38 AM EDT - 1 year ago

Microbot Medical Announces the Successful Completion of its Pivotal Human Clinical Trial; Accelerates Go-to-Market Strategy to Prepare for Commercial Launch of LIBERTY® during 2Q 2025

Sep 30, 2024, 8:30 AM EDT - 1 year ago

Microbot Medical Accelerates Patient Enrollment of its Pivotal Human Clinical Trial; Expects to Complete the Trial Earlier Than Anticipated as 80% of Patients Have Completed Follow up

Sep 17, 2024, 8:30 AM EDT - 1 year ago

Microbot Medical Announces the Successful Enrollment of 50% of the Patients in its Pivotal Human Clinical Trial for the LIBERTY Endovascular Robotic Surgical System

Aug 22, 2024, 8:30 AM EDT - 1 year ago

Microbot Medical Signs Phase 2 Collaboration Agreement with Corewell Health to Advance Remote Telesurgery Using the LIBERTY® Endovascular Robotic System

Aug 13, 2024, 8:30 AM EDT - 1 year ago

Microbot Medical Receives Quality Certification to Support Future Regulatory Submissions and Commercialization

Aug 1, 2024, 8:30 AM EDT - 1 year ago

Microbot Medical and Emory University to Evaluate the Future Autonomous Capabilities of the LIBERTY® Endovascular Robotic Surgical System

Jul 18, 2024, 8:30 AM EDT - 1 year ago

Microbot Medical Completes the Enrollment of Clinical Sites in Its Pivotal Human Clinical Trial with the Addition of Memorial Sloan Kettering Cancer Center

Jul 9, 2024, 8:30 AM EDT - 1 year ago

Microbot Medical Continues to Ramp Up Patient Enrollment in its Pivotal Human Clinical Trial

ImCrazy Apr. 8 at 1:51 AM

$MBOT

0 · Reply

trigger_finger Apr. 7 at 11:35 PM

$MBOT

3 · Reply

trigger_finger Apr. 7 at 4:32 PM

1 · Reply

DragonAlgo Apr. 7 at 1:17 PM

0 · Reply

Vladdavceo Apr. 7 at 1:15 AM

$BIOLLM.X $MBOT

0 · Reply

MakeM0ney_444 Apr. 6 at 6:57 PM

$MBOT amazing, but why didn’t this move the sp much today? Do we see a big jump next week?

2 · Reply

trigger_finger Apr. 6 at 6:04 PM

$MBOT If support breaks, this is what I would be looking at.

3 · Reply

Eddypgil Apr. 6 at 4:05 PM

$MBOT building in hingham looks pretty sleepy. Maybe the engineer at Microbot can try and get liberty to work with Synchrony

1 · Reply

ImCrazy Apr. 6 at 3:54 PM

$MBOT https://www.sirweb.org/education/events/sir-2026-annual-scientific-meeting/

0 · Reply

ImCrazy Apr. 6 at 3:53 PM

0 · Reply

trigger_finger Apr. 6 at 3:29 PM

$MBOT $STXS 200 procedures a year on Liberty and a hospital could own a Genesis X, Synchrony and Synx. What is going to drive more value to the hospital, that is the question anyone should be asking themself. Financial comparison coming.

4 · Reply

Eddypgil Apr. 6 at 2:23 PM

$MBOT latency is an issue

2 · Reply

GaryBx105 Apr. 6 at 1:44 PM

$MBOT close above $2.41 triggers AmericanBulls buy signal.

0 · Reply

Prash83 Apr. 6 at 10:16 AM

$MBOT More tax free investment! ISA investors

1 · Reply

Daquanladariusblackman3 Apr. 6 at 4:55 AM

$MBOT $STXS so you literally just proved the point of the problem MBOT is attempting to solve by not having a large capital investment and heavy machinery. There is a reason the liberty is going to be sold as a box set with multiple coming from one order. Guy can’t even do his own research and needs to rely on AI as a crutch, what a hack. Nothing you are saying hasn’t been brought up before and countered already. Continue to lose money with STXS and stubbornly attack a board on ST on the account of @Eddypgil some dickneck you don’t even know. I’m sure you’ll make alot of headway with that.

1 · Reply

Daquanladariusblackman3 Apr. 6 at 4:45 AM

$MBOT Lmaoo guy puts an 80s gaming system in the picture then says all his posts will be factual and not opinionated. What a joke. Don’t worry trigger we’ve had plenty of bears and hacks like you and Eddy plaguing the board for over a year. Some like the longest standing one @kamenrider888 have given up because they’ve seen the error of their ways. Just so everyone here knows @trigger_finger is only carrying on with this bullshit because I took it upon myself to razz the $STXS board on account of our favorite resident bear @Eddypgil refusing to STFU. Trigger do your worst bud nothing you say or do or weigh in on will affect the liberty being adopted in the slightest. Gfym tiny man.

3 · Reply

trigger_finger Apr. 6 at 2:47 AM

$MBOT Know what you are buying.

3 · Reply

trigger_finger Apr. 6 at 2:06 AM

$MBOT $STXS This is unbelievably sad. Even with Grok, Gemini, Chatgpt, and Claude available for free this poor low IQ Mbot investor is doubling down... Go to any of these free AI tools dude, look up when it happened. Even after I tell you, you are too dumb to figure it out. A leased Genesis X w/ Sychrony and Synx, a year supply of Magic will cost the same as 200 procedures of MBOT per year. I had zero interest in MBOT, now I do. Not good for MBOT.

0 · Reply

trigger_finger Apr. 6 at 1:38 AM

$STXS $MBOT This is an MBOT investor. Congratulations MBOT! Just goes to show you that even with the world's information at your fingertips, there will be people that are so dumb they can't even get a decade right. This low IQ individual thought this was clever. 😂

3 · Reply

Eddypgil Apr. 5 at 10:26 AM

$MBOT institutions now own 17% of outstanding shares

0 · Reply

Vladdavceo Apr. 5 at 3:33 AM

$MBOT https://www.msn.com/en-us/news/other/biollm%E2%80%99s-exploration-of-ai%E2%80%99s-unexpected-evolution/ar-AA1ZozaF?disableErrorRedirect=true&infiniteContentCount=0 $BIOLLM.X #BioLLM @BioLLM http://BioLLM.com 🧬🧠

0 · Reply

Daquanladariusblackman3 Apr. 4 at 6:27 PM

$MBOT yet again Eddy worry about your own investments. MBOT has a full market release of the liberty coming up this month with two hospitals already signed on for adoption. STXS on the other hand is hemorrhaging money, and keeps tanking lower, and lower, and lower. Much more likely that $STXS needs a reverse split, massive dilution, or a buyout to save their ass l. That ticker is dead money and your losses are large. @trigger_finger you starting to see why I’m hitting back on the $STXS board? This nonsense from this jackass and that hack @alexpitti has been going in for the better part of a year.

3 · Reply

Market Cap	158.49M
Revenue (ttm)	0.00
Net Income (ttm)	-13.14M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	954,000
Avg Vol	2,179,594
Day's Range	N/A - N/A
Shares Out	67.16M
Stochastic %K	7%
Beta	1.19
Analysts	Strong Sell
Price Target	$7.50